Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CHD1 Produkte

(Chromodomain Helicase DNA Binding Protein 1 (CHD1))

Kategorien

The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. [provided by RefSeq, Jul 2008].

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte CHD1 Kategorien

CHD1 Antikörper

High quality antibodies with extensive validation data.

Empfohlene CHD1 Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Applikation WB, IHC
Validierungen
  • (5)
Kat. Nr. ABIN6138500
Menge 100 μL
Datenblatt Datenblatt
Reaktivität Human
Applikation ELISA, IHC, ChIP
Validierungen
  • (3)
Kat. Nr. ABIN7147714
Menge 100 μL
Datenblatt Datenblatt
Reaktivität Human
Applikation WB, ELISA, IF
Validierungen
  • (3)
Kat. Nr. ABIN514372
Menge 100 μg
Datenblatt Datenblatt

Empfohlene CHD1 ELISA Kits

Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Analytical Method Quantitative Sandwich ELISA
Validierungen
Kat. Nr. ABIN6202835
Menge 96 tests
Datenblatt Datenblatt

Empfohlene CHD1 Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Source Wheat germ
Validierungen
  • (1)
Kat. Nr. ABIN1349288
Menge 10 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren CHD1 Produkten

Skene, Hernandez, Groudine, Henikoff: "The nucleosomal barrier to promoter escape by RNA polymerase II is overcome by the chromatin remodeler Chd1." in: eLife, Vol. 3, pp. e02042, (2014) (PubMed).

Burkhardt, Fuchs, Krohn, Masser, Mader, Kluth, Bachmann, Huland, Steuber, Graefen, Schlomm, Minner, Sauter, Sirma, Simon: "CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer." in: Cancer research, Vol. 73, Issue 9, pp. 2795-805, (2013) (PubMed).

Liu, Lindberg, Sui, Luo, Egevad, Li, Xie, Wan, Kim, Wang, Turner, Zhang, Feng, Yan, Sun, Bova, Ewing, Yan, Gielzak, Cramer, Vessella, Zheng, Grönberg, Isaacs, Xu: "Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer." in: Oncogene, Vol. 31, Issue 35, pp. 3939-48, (2012) (PubMed).

Huang, Gulzar, Salari, Lapointe, Brooks, Pollack: "Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness." in: Oncogene, Vol. 31, Issue 37, pp. 4164-70, (2012) (PubMed).

Gallastegui, Millán-Zambrano, Terme, Chávez, Jordan: "Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency." in: Journal of virology, Vol. 85, Issue 7, pp. 3187-202, (2011) (PubMed).

Tao, Liu, Briones, Geiman, Muegge: "Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS." in: Nucleic acids research, Vol. 39, Issue 22, pp. 9508-20, (2011) (PubMed).

Yoshimura, Harada, Odawara, Azuma, Okada, Nakamura, Ohkawa, Tachibana: "Rat monoclonal antibody specific for the chromatin remodeling factor, CHD1." in: Hybridoma (2005), Vol. 29, Issue 3, pp. 237-40, (2010) (PubMed).

Tao, Xi, Briones, Muegge: "Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation." in: PLoS ONE, Vol. 5, Issue 2, pp. e9163, (2010) (PubMed).

Eissenberg, Lee, Schneider, Ilvarsonn, Shiekhattar, Shilatifard: "The trithorax-group gene in Drosophila little imaginal discs encodes a trimethylated histone H3 Lys4 demethylase." in: Nature structural & molecular biology, Vol. 14, Issue 4, pp. 344-6, (2007) (PubMed).

Cheng, Tan, Ganesan, Drake: "Integrating phosphoproteomics into the clinical management of prostate cancer." in: Clinical and translational medicine, Vol. 6, Issue 1, pp. 9 (PubMed).

Synonyme und alternative Namen zu CHD1

chromodomain helicase DNA binding protein 1 (CHD1), Chromodomain-helicase-DNA-binding protein (CHD1), chromodomain helicase DNA binding protein 1 (Chd1), Chromodomain-helicase-DNA-binding protein 1 (Chd1), chromodomain helicase DNA binding protein 1 (CHDB1), 4930525N21Rik, AI851787, AW555109, CG3733, CHD-1, CHD1, chd1, CHD1W, dCHD1, DmCHD1, Dmel\\CG3733, l(2)23Cd

Bezeichner auf Proteinebene für CHD1

  • ATP-dependent helicase CHD1
  • CHD-1
  • chromodomain-helicase-DNA-binding protein 1
  • chromo-helicase/ATPase-DNA binding protein 1
  • chromodomain helicase DNA binding protein 1
  • CG3733-PA
  • CG3733-PB
  • CG3733-PC
  • Chd1-PA
  • Chd1-PB
  • Chd1-PC
  • Chromodomain-helicase-DNA-binding protein
  • chromo-ATPase/helicase-DNA-binding domain
  • chromo-ATPase/helicase-DNA-binding protein 1
  • lethal (2) 23Cd
  • LOW QUALITY PROTEIN: chromodomain-helicase-DNA-binding protein 1
Sie sind hier:
Kundenservice